Oral bioavailability of a low molecular weight heparin using a polymeric delivery system-Reference-Cited by-同舟云学术

Oral bioavailability of a low molecular weight heparin using a polymeric delivery system

Published:2006-06 Issue:1 Volume:113 Page:38-42
ISSN:0168-3659
Container-title:Journal of Controlled Release
language:en
Short-container-title:Journal of Controlled Release

Author:

Hoffart Valérie,Lamprecht Alf,Maincent Philippe,Lecompte Thomas,Vigneron Claude,Ubrich Nathalie

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference30 articles.

1. Heparin;Hirsh;N. Engl. Med.,1991

2. Oral administration of low molecular weight heparin fractions in rabbits;Doutremepuich;Semin. Thromb. Hemost.,1985

3. The economic impact of treating deep vein thrombosis with low molecular weight heparin: outcome of therapy and health economy aspects;Hull;Haemostasis,1998

4. Low-molecular-weight heparins and thrombocytosis;Liautard;Ann. Pharmacother.,2002

5. Care of patients receiving long-term anticoagulant therapy (clinical practice);Schulman;N. Engl. J. Med.,2003

Cited by 111 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Orally administrated fucoidan and its low-molecular-weight derivatives are absorbed differentially to alleviate coagulation and thrombosis;International Journal of Biological Macromolecules;2024-01

2. Naturally and Chemically Sulfated Polysaccharides in Drug Delivery Systems;Advanced Pharmacy;2023-09-25

3. Polymeric nanoparticles containing babassu oil: A proposed drug delivery system for controlled release of hydrophilic compounds;Chemistry and Physics of Lipids;2023-07

4. Preparation of nanodelivery systems for oral administration of low molecular weight heparin;Journal of Drug Delivery Science and Technology;2023-01

5. Doxycycline hyclate-loaded Eudragit® RS PO in situ-forming microparticles for periodontitis treatment;Journal of Drug Delivery Science and Technology;2022-05